Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cowen

Showing results (311-320 of 651) with videos related to

Pageof 66
Sort By:
Analytical Chemistry|November 28, 2001
Array-to-array transfer of an artificial nose classifierS E Stitzel, L J Cowen, K J Albert, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1995
Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patientsD J Williamson, S F McTavish, S B Park, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Acute reboxetine administration increases plasma and salivary cortisolS A Hill, M J Taylor, C J Harmer, et al.
The Journal of Clinical Psychiatry|April 9, 2005
Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patientsAnn L Sharpley, Mary E J Attenburrow, Sepehr Hafizi, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
The effect of metergoline on endocrine responses to L-tryptophanS L McCance, P J Cowen, H Waller, et al.
Psychopharmacology|January 1, 1989
Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjectsN R Best, D H Barlow, M P Rees, et al.
Biological Psychiatry|August 1, 1989
Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteersP M Grasby, E J Begg, S E Gartside, et al.
The International Journal of Neuropsychopharmacology|September 18, 2010
Elevated cortical glutamate in young people at increased familial risk of depressionMatthew J Taylor, Zola N Mannie, Ray Norbury, et al.
Journal of Psychopharmacology (Oxford, England)|March 17, 2011
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processingJamie Horder, Michael Browning, Martina Di Simplicio, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2018
The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopramD Arnone, T Wise, C Walker, et al.
Pageof 66

Showing results (311-320 of 651) with videos related to

Sort By:
Pageof 66
Analytical Chemistry|November 28, 2001
Array-to-array transfer of an artificial nose classifierS E Stitzel, L J Cowen, K J Albert, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1995
Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patientsD J Williamson, S F McTavish, S B Park, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Acute reboxetine administration increases plasma and salivary cortisolS A Hill, M J Taylor, C J Harmer, et al.
The Journal of Clinical Psychiatry|April 9, 2005
Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patientsAnn L Sharpley, Mary E J Attenburrow, Sepehr Hafizi, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
The effect of metergoline on endocrine responses to L-tryptophanS L McCance, P J Cowen, H Waller, et al.
Psychopharmacology|January 1, 1989
Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjectsN R Best, D H Barlow, M P Rees, et al.
Biological Psychiatry|August 1, 1989
Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteersP M Grasby, E J Begg, S E Gartside, et al.
The International Journal of Neuropsychopharmacology|September 18, 2010
Elevated cortical glutamate in young people at increased familial risk of depressionMatthew J Taylor, Zola N Mannie, Ray Norbury, et al.
Journal of Psychopharmacology (Oxford, England)|March 17, 2011
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processingJamie Horder, Michael Browning, Martina Di Simplicio, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2018
The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopramD Arnone, T Wise, C Walker, et al.
Pageof 66